170 related articles for article (PubMed ID: 16518858)
1. Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer.
Ulmer TA; Keeler V; Loh L; Chibbar R; Torlakovic E; André S; Gabius HJ; Laferté S
J Cell Biochem; 2006 Aug; 98(5):1351-66. PubMed ID: 16518858
[TBL] [Abstract][Full Text] [Related]
2. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion.
Inohara H; Akahani S; Koths K; Raz A
Cancer Res; 1996 Oct; 56(19):4530-4. PubMed ID: 8813152
[TBL] [Abstract][Full Text] [Related]
3. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.
Bresalier RS; Byrd JC; Wang L; Raz A
Cancer Res; 1996 Oct; 56(19):4354-7. PubMed ID: 8813123
[TBL] [Abstract][Full Text] [Related]
4. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies specific for human tumor-associated antigen 90K/Mac-2 binding protein: tools to examine protein conformation and function.
Laferté S; Loh LC; Keeler V
J Cell Biochem; 2000 Apr; 77(4):540-59. PubMed ID: 10771511
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation.
Song S; Byrd JC; Mazurek N; Liu K; Koo JS; Bresalier RS
Gastroenterology; 2005 Nov; 129(5):1581-91. PubMed ID: 16285957
[TBL] [Abstract][Full Text] [Related]
7. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin.
Sasaki T; Brakebusch C; Engel J; Timpl R
EMBO J; 1998 Mar; 17(6):1606-13. PubMed ID: 9501082
[TBL] [Abstract][Full Text] [Related]
8. Integrin alpha3beta1 expressed by human colon cancer cells is a major carrier of oncodevelopmental carbohydrate epitopes.
Prokopishyn NL; Puzon-McLaughlin W; Takada Y; Laferté S
J Cell Biochem; 1999 Feb; 72(2):189-209. PubMed ID: 10022502
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells.
Ohannesian DW; Lotan D; Thomas P; Jessup JM; Fukuda M; Gabius HJ; Lotan R
Cancer Res; 1995 May; 55(10):2191-9. PubMed ID: 7743523
[TBL] [Abstract][Full Text] [Related]
10. Involvement of 90K/Mac-2 binding protein in cancer metastases by increased cellular adhesiveness in lung cancer.
Ozaki Y; Kontani K; Teramoto K; Fujita T; Tezuka N; Sawai S; Maeda T; Watanabe H; Fujino S; Asai T; Ohkubo I
Oncol Rep; 2004 Nov; 12(5):1071-7. PubMed ID: 15492795
[TBL] [Abstract][Full Text] [Related]
11. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion.
Zou J; Glinsky VV; Landon LA; Matthews L; Deutscher SL
Carcinogenesis; 2005 Feb; 26(2):309-18. PubMed ID: 15528216
[TBL] [Abstract][Full Text] [Related]
12. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.
Valenzuela HF; Pace KE; Cabrera PV; White R; Porvari K; Kaija H; Vihko P; Baum LG
Cancer Res; 2007 Jul; 67(13):6155-62. PubMed ID: 17616672
[TBL] [Abstract][Full Text] [Related]
13. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein.
Lee JH; Cho ES; Kim MY; Seo YW; Kho DH; Chung IJ; Kook H; Kim NS; Ahn KY; Kim KK
Cancer Res; 2005 Oct; 65(19):8993-9003. PubMed ID: 16204073
[TBL] [Abstract][Full Text] [Related]
14. Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma.
Ozaki Y; Kontani K; Hanaoka J; Chano T; Teramoto K; Tezuka N; Sawai S; Fujino S; Yoshiki T; Okabe H; Ohkubo I
Cancer; 2002 Nov; 95(9):1954-62. PubMed ID: 12404290
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3.
Fry SA; Van den Steen PE; Royle L; Wormald MR; Leathem AJ; Opdenakker G; McDonnell JM; Dwek RA; Rudd PM
Biochemistry; 2006 Dec; 45(51):15249-58. PubMed ID: 17176047
[TBL] [Abstract][Full Text] [Related]
16. Multifaceted role of galectin-3 on human glioblastoma cell motility.
Debray C; Vereecken P; Belot N; Teillard P; Brion JP; Pandolfo M; Pochet R
Biochem Biophys Res Commun; 2004 Dec; 325(4):1393-8. PubMed ID: 15555581
[TBL] [Abstract][Full Text] [Related]
17. Cell surface overexpression of galectin-3 and the presence of its ligand 90k in the blood plasma as determinants in colon neoplastic lesions.
Greco C; Vona R; Cosimelli M; Matarrese P; Straface E; Scordati P; Giannarelli D; Casale V; Assisi D; Mottolese M; Moles A; Malorni W
Glycobiology; 2004 Sep; 14(9):783-92. PubMed ID: 15140826
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of interaction between NG2 proteoglycan and galectin-3.
Wen Y; Makagiansar IT; Fukushi J; Liu FT; Fukuda MN; Stallcup WB
J Cell Biochem; 2006 May; 98(1):115-27. PubMed ID: 16365873
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3, a laminin binding protein, fails to modulate adhesion of human melanoma cells to laminin.
van den Brûle FA; Buicu C; Sobel ME; Liu FT; Castronovo V
Neoplasma; 1995; 42(5):215-9. PubMed ID: 8552198
[TBL] [Abstract][Full Text] [Related]
20. On the role of galectin-3 in cancer apoptosis.
Nakahara S; Oka N; Raz A
Apoptosis; 2005 Mar; 10(2):267-75. PubMed ID: 15843888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
